Grifols and Corporación Mondragón sign agreement to jointly develop technology and infrastructure projects in the health sector
Grifols y Corporación Mondragón firman una alianza para desarrollar conjuntamente proyectos de tecnologías e infraestructuras en el sector de la salud
Intel ID : 276013
Relevant Documents
| Press Release | 06 Sep 2019 | Grifols_Nota_de_Prensa_2019.pdf | ES |
|
| Intel ID | 276013 | ||||
| Value | ND | ||||
| Native Currency | Euro (EUR) | ||||
|
Financial Data - Grifols
(31 Dec 2023) |
Revenue: EUR 7.077,97m EBITDA: EUR 1.247,56m Net Debt: EUR 10.541,45m |
||||
| Date |
 |
||||
| Country | |
||||
| Geography | |
||||
| Subsector (Old TTR Sectors) |
|
||||
| Type |
|
||||
| Intel Grade |
 |
||||
| Source |
|
||||
| Tags | |
Bidder
| Name |
|
|||
| Subsector (Old TTR Sectors) |
|
|||
| Primary Sector (TTRSC) |
25.01.04 Consumer Finance 25 Financial Services / 25.01 Banking & Investment |
|||
| Secondary Sectors (TTRSC) |
15.05.08 Food & Beverage Retail 15 Consumer Products & Services / 15.05 Distribution & Retail 15.06.01 Colleges & Universities 15 Consumer Products & Services / 15.06 Education & Training Services 25.04.03 Holding Companies / Financial Holding Companies 25 Financial Services / 25.04 Other Financial Services 35.06.99 Other Industrial Services 35 Industrials / 35.06 Industrial Services |
|||
| Country |
|
|||
| Website |
|
|||
| Description |
|
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.